尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Olagunju Peter. Officer active across 1 company, notably TCR2 THERAPEUTICS INC.. In total, 5 disclosures have been published. Split: 0 buy · 3 sells. Total volume traded: €5k. History available since 5 December 2022. The latest transaction was disclosed on 9 December 2022 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Olagunju Peter is a declarant linked to TCR2 THERAPEUTICS INC. on XNAS, where he is Chief Operating Officer. Across 5 filings, the 5 sampled filings run from 2022-12-05 to 2023-06-01 and show 0 euros of buys and 5034 euros of sells, with Cession as the dominant transaction nature.